Effect of sotagliflozin as an adjunct to insulin therapy on blood pressure and arterial stiffness in adults with type 1 diabetes: A post hoc pooled analysis of inTandem1 and inTand...

por Rodbard, Helena W, Giaccari, Andrea, Cariou, Bertrand, Garg, Satish, Davies, Michael J, Seth, Kiernan, Sawhney, Sangeeta
Publicado 2021

Sotagliflozin Added to Optimized Insulin Therapy Leads to Lower Rates of Clinically Relevant Hypoglycemic Events at Any HbA1c at 52 Weeks in Adults with Type 1 Diabetes

por Danne, Thomas, Pettus, Jeremy, Giaccari, Andrea, Cariou, Bertrand, Rodbard, Helena, Weinzimer, Stuart A., Bonnemaire, Mireille, Sawhney, Sangeeta, Stewart, John, Wang, Stella, Castro, Rita de Cassia, Garg, Satish K.
Publicado 2019

Diabetic Ketoacidosis and Related Events With Sotagliflozin Added to Insulin in Adults With Type 1 Diabetes: A Pooled Analysis of the inTandem 1 and 2 Studies

por Peters, Anne L., McGuire, Darren K., Danne, Thomas, Kushner, Jake A., Rodbard, Helena W., Dhatariya, Ketan, Sawhney, Sangeeta, Banks, Phillip, Jiang, Wenjun, Davies, Michael J., Lapuerta, Pablo
Publicado 2020

Dose‐dependent glycometabolic effects of sotagliflozin on type 1 diabetes over 12 weeks: The inTandem4 trial

por Baker, Claire, Wason, Suman, Banks, Phillip, Sawhney, Sangeeta, Chang, Anna, Danne, Thomas, Gesty‐Palmer, Diane, Kushner, Jake A., McGuire, Darren K., Mikell, Frank, O'Neill, Mark, Peters, Anne L., Strumph, Paul
Publicado 2019